Prescription drug pricing; prohibiting certain action. Effective date.

SB 1030, the "340B Drug Pricing Nondiscrimination Act," prohibits Oklahoma health insurers, pharmacy benefits managers, and third-party payors from discriminating against 340B entities (like community health centers and hospitals participating in the federal 340B drug pricing program). It requires equal payment rates for 340B drugs compared to non-340B drugs, bans extra fees or restrictions solely because an entity uses 340B pricing, and prevents interference with patient choice to receive 340B drugs. The law directly affects 340B-covered entities and their payers, ensuring they are not subject to additional administrative burdens or lower reimbursements due to their participation in the federal program. This bill aims to align Oklahoma’s reimbursement practices with federal 340B program protections.